Table 2 Association of admission sex and mineralocorticoid hormone metabolite levels with short- and long-term all-cause mortality in males with CAP

Progesterone

Cox regression analyses

0.66 (95%CI 0.11–3.83)

p = 0.643

0.66 (95%CI 0.34–1.31)

p = 0.239

0.69 (95%CI 0.40–1.18)

p = 0.178

17-OH-Progesterone

Cox regression analyses

0.72 (95%CI 0.35–1.48)

p = 0.369

0.66 (95%CI 0.47–0.92)

p = 0.015

0.72 (95%CI 0.54–0.97)

p = 0.029

Aldosterone

Cox regression analyses

1.91 (95%CI 0.55–6.63)

p = 0.310

1.25 (95%CI 0.74–2.12)

p = 0.410

0.89 (95%CI 0.59–1.33)

p = 0.565

DHEA

Cox regression analyses

0.16 (95%CI 0.01–3.79)

p = 0.255

0.67 (95%CI 0.35–1.27)

p = 0.221

DHEA-S

Cox regression analyses

0.57 (95%CI 0.01–25.17)

p = 0.768

0.69 (95%CI 0.20–2.42)

p = 0.562

0.55 (95%CI 0.18–1.67)

p = 0.293

Androstenedione

Cox regression analyses

5.46 (95%CI 0.85–35.12)

p = 0.074

0.59 (95%CI 0.34–0.99)

p = 0.049

0.65 (95%CI 0.40–1.05)

p = 0.081

Testosterone

Cox regression analyses

0.69 (95%CI 0.16–2.94)

p = 0.613

1.36 (95%CI 0.73–2.52)

p = 0.328

1.04 (95%CI 0.64–1.72)

p = 0.865

Dihydrotestosterone

Cox regression analyses

6.08 (95%CI 0.15–254.59)

p = 0.344

2.0 (95%CI 0.64–6.27)

p = 0.236

2.84 (95%CI 1.15–6.99)

p = 0.023